The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors

Descripción del Articulo

Financial support was received from The Wellcome Trust Travel Awards 2000, 2002; TWAS 02-051; CONCYTEC: 2002-2003, 441-2004 and PUCP-DAI: 3054, 0198, 3414, and E-032.
Detalles Bibliográficos
Autores: Galarreta B.C., Sifuentes R., Carrillo A.K., Sanchez L., Amado M.d.R.I., Maruenda H.
Formato: artículo
Fecha de Publicación:2008
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/945
Enlace del recurso:https://hdl.handle.net/20.500.12390/945
https://doi.org/10.1016/j.bmc.2008.05.074
Nivel de acceso:acceso abierto
Materia:Trypanosomatid
Trypanothione reductase
Enzymatic inhibition
id CONC_3a49478c4a85b39ecbad51a001fd7cd6
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/945
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
title The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
spellingShingle The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
Galarreta B.C.
Trypanosomatid
Trypanothione reductase
Enzymatic inhibition
title_short The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
title_full The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
title_fullStr The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
title_full_unstemmed The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
title_sort The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors
author Galarreta B.C.
author_facet Galarreta B.C.
Sifuentes R.
Carrillo A.K.
Sanchez L.
Amado M.d.R.I.
Maruenda H.
author_role author
author2 Sifuentes R.
Carrillo A.K.
Sanchez L.
Amado M.d.R.I.
Maruenda H.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Galarreta B.C.
Sifuentes R.
Carrillo A.K.
Sanchez L.
Amado M.d.R.I.
Maruenda H.
dc.subject.en.fl_str_mv Trypanosomatid
Trypanothione reductase
Enzymatic inhibition
topic Trypanosomatid
Trypanothione reductase
Enzymatic inhibition
description Financial support was received from The Wellcome Trust Travel Awards 2000, 2002; TWAS 02-051; CONCYTEC: 2002-2003, 441-2004 and PUCP-DAI: 3054, 0198, 3414, and E-032.
publishDate 2008
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2008
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/945
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.bmc.2008.05.074
dc.identifier.scopus.none.fl_str_mv 2-s2.0-47349130269
url https://hdl.handle.net/20.500.12390/945
https://doi.org/10.1016/j.bmc.2008.05.074
identifier_str_mv 2-s2.0-47349130269
dc.language.iso.none.fl_str_mv eng
language eng
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.en.fl_str_mv Elsevier Ltd
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1844882991793307648
spelling Publicationrp02586600rp02587600rp02584600rp02477400rp02585600rp00916500Galarreta B.C.Sifuentes R.Carrillo A.K.Sanchez L.Amado M.d.R.I.Maruenda H.2024-05-30T23:13:38Z2024-05-30T23:13:38Z2008https://hdl.handle.net/20.500.12390/945https://doi.org/10.1016/j.bmc.2008.05.0742-s2.0-47349130269Financial support was received from The Wellcome Trust Travel Awards 2000, 2002; TWAS 02-051; CONCYTEC: 2002-2003, 441-2004 and PUCP-DAI: 3054, 0198, 3414, and E-032.Twenty-three heterocyclic compounds were evaluated for their potential as trypanothione reductase inhibitors. As a result, the harmaline, 10-thiaisoalloxazine, and aspidospermine frameworks were identified as the basis of inhibitors of Trypanosoma cruzi trypanothione reductase. Two new compounds showed moderately strong, linear competitive inhibition, namely N,N-dimethyl-N-[3-(7-methoxy-1- methyl-3,4-dihydro-9H-b-carbolin-9-yl)propyl]amine (15) and 1,3-bis[3-(dimethylamino)propyl]-1,5- dihydro-2H-pyrimido[4,5-b][1,4]benzothiazine-2,4(3H)-dione (21), with Ki values of 35.1 ± 3.5 lM and 26.9 ±1.9 lM, respectively. Aspidospermine (25) inhibited T. cruzi TryR with a Ki of 64.6 ± 6.2 lM. None of the compounds inhibited glutathione reductase. Their toxicity toward promastigotes of Leishmania amazonensis was assessed.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengElsevier Ltdinfo:eu-repo/semantics/openAccessTrypanosomatidTrypanothione reductaseEnzymatic inhibitionThe use of natural product scaffolds as leads in the search for trypanothione reductase inhibitorsinfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#20.500.12390/945oai:repositorio.concytec.gob.pe:20.500.12390/9452025-09-23 15:54:30.409http://purl.org/coar/access_right/c_14cbinfo:eu-repo/semantics/closedAccessmetadata only accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="7e2a4619-6e80-4f55-bc75-7d623f15c42d"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>The use of natural product scaffolds as leads in the search for trypanothione reductase inhibitors</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2008</PublicationDate> <DOI>https://doi.org/10.1016/j.bmc.2008.05.074</DOI> <SCP-Number>2-s2.0-47349130269</SCP-Number> <Authors> <Author> <DisplayName>Galarreta B.C.</DisplayName> <Person id="rp02586" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Sifuentes R.</DisplayName> <Person id="rp02587" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Carrillo A.K.</DisplayName> <Person id="rp02584" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Sanchez L.</DisplayName> <Person id="rp02477" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Amado M.d.R.I.</DisplayName> <Person id="rp02585" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Maruenda H.</DisplayName> <Person id="rp00916" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Elsevier Ltd</DisplayName> <OrgUnit /> </Publisher> </Publishers> <Keyword>Trypanosomatid</Keyword> <Keyword>Trypanothione reductase</Keyword> <Keyword>Enzymatic inhibition</Keyword> <Abstract>Twenty-three heterocyclic compounds were evaluated for their potential as trypanothione reductase inhibitors. As a result, the harmaline, 10-thiaisoalloxazine, and aspidospermine frameworks were identified as the basis of inhibitors of Trypanosoma cruzi trypanothione reductase. Two new compounds showed moderately strong, linear competitive inhibition, namely N,N-dimethyl-N-[3-(7-methoxy-1- methyl-3,4-dihydro-9H-b-carbolin-9-yl)propyl]amine (15) and 1,3-bis[3-(dimethylamino)propyl]-1,5- dihydro-2H-pyrimido[4,5-b][1,4]benzothiazine-2,4(3H)-dione (21), with Ki values of 35.1 ± 3.5 lM and 26.9 ±1.9 lM, respectively. Aspidospermine (25) inhibited T. cruzi TryR with a Ki of 64.6 ± 6.2 lM. None of the compounds inhibited glutathione reductase. Their toxicity toward promastigotes of Leishmania amazonensis was assessed.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.877373
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).